Patents by Inventor Ian Sargent

Ian Sargent has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYNCYTIOTROPHOBLAST EXTRACELLULAR VESICLES AS BIOMARKER FOR GESTATIONAL DIABETES MELLITUS
    Publication number: 20210140946
    Abstract: The present invention relates to a method of determining the gestational diabetic status of a pregnant subject, comprising providing a biological sample obtained from the subject; and determining the presence, and/or level, of syncytiotrophoblast extracellular vesicles, and/or insulin receptor, and/or DPPIV in the biological sample.
    Type: Application
    Filed: June 1, 2018
    Publication date: May 13, 2021
    Inventors: Manu VATISH, Ian SARGENT, Neva KANDZIJA, Wei ZHANG, Dionne TANNETTA
  • BIOMARKERS AND USES THEREOF
    Publication number: 20210116459
    Abstract: A method of determining the pre-eclampsia status of a pregnant subject, comprising providing a biological sample obtained from the subject; and determining the presence or absence, and/or level, of one or more of Type XVII collagen alpha 1, leptin, neprilysin, Filamin B and Scavenger receptor class B member 1 in the biological sample, and preferably comparing the level determined with a control.
    Type: Application
    Filed: April 11, 2019
    Publication date: April 22, 2021
    Inventors: Manu VATISH, Christopher REDMAN, Ian SARGENT, Adam CRIBBS, Gavin COLLETT, Wei ZHANG
  • DIAGNOSTIC METHOD
    Publication number: 20130210040
    Abstract: It has been demonstrated that the level of sST2 increases in pregnant females suffering from pre-eclampsia. Accordingly, the level of sST2 in a pregnant female can be used to assess risk of developing pre-eclampsia.
    Type: Application
    Filed: August 3, 2011
    Publication date: August 15, 2013
    Applicant: ISIS INNOVATION LIMITED
    Inventors: Ian Sargent, Jennifer Southcombe, Ingrid Granne
  • Fibronectin variants and screening methods
    Publication number: 20050118661
    Abstract: A method is provided for assessing fertility status in female patient which comprises determining the level of fibronectin isoform EDIIIA+ and/or EDIIIB+ in an isolated endometrial sample within the implantation window time for the patient and correlating the appearance of said fibronectin isoform with fertility status. Fibronectin variants useful as contraceptive agents are also described.
    Type: Application
    Filed: July 21, 2004
    Publication date: June 2, 2005
    Inventors: Helen Mardon, David Barlow, Ian Sargent, Christopher Van derWalle